These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29308405)

  • 1. AIDS-Defining Illnesses at Initial Diagnosis of HIV in a Large Guatemalan Cohort.
    Reinhardt SW; Spec A; Meléndez J; Alonzo Cordon A; Ross I; Powderly WG; Mejia Villatoro C
    Open Forum Infect Dis; 2017; 4(4):ofx249. PubMed ID: 29308405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia.
    Chow JY; Alsan M; Armstrong W; del Rio C; Marconi VC
    AIDS Care; 2015; 27(7):844-8. PubMed ID: 25660100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
    Grabar S; Lanoy E; Allavena C; Mary-Krause M; Bentata M; Fischer P; Mahamat A; Rabaud C; Costagliola D;
    HIV Med; 2008 Apr; 9(4):246-56. PubMed ID: 18366449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-defining illnesses: a comparison between before and after commencement of highly active antiretroviral therapy (HAART).
    Lian YL; Heng BS; Nissapatorn V; Lee C
    Curr HIV Res; 2007 Sep; 5(5):484-9. PubMed ID: 17896968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing trends in clinical AIDS presentations and survival among HIV-1-infected women.
    Charurat M; Blattner W; Hershow R; Buck A; Zorrilla CD; Watts DH; Paul M; Landesman S; Adeniyi-Jones S; Tuomala R;
    J Womens Health (Larchmt); 2004; 13(6):719-30. PubMed ID: 15333287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
    Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
    Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
    Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
    J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.
    Lima VD; Lourenço L; Yip B; Hogg RS; Phillips P; Montaner JS
    Lancet HIV; 2015 Mar; 2(3):e92-7. PubMed ID: 25780802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
    Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
    Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia.
    Dore GJ; Li Y; McDonald A; Ree H; Kaldor JM;
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):388-95. PubMed ID: 11917244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses.
    Conti S; Masocco M; Pezzotti P; Toccaceli V; Vichi M; Boros S; Urciuoli R; Valdarchi C; Rezza G
    J Acquir Immune Defic Syndr; 2000 Dec; 25(5):451-8. PubMed ID: 11141245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS).
    Bellamy R; Sangeetha S; Paton NI
    BMC Infect Dis; 2004 Nov; 4():47. PubMed ID: 15538953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS in Africa--survival according to AIDS-defining illness.
    Post FA; Badri M; Wood R; Maartens G
    S Afr Med J; 2001 Jul; 91(7):583-6. PubMed ID: 11544975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014.
    Tanuma J; Lee KH; Haneuse S; Matsumoto S; Nguyen DT; Nguyen DT; Do CD; Pham TT; Nguyen KV; Oka S
    PLoS One; 2016; 11(3):e0150781. PubMed ID: 26939050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.
    Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ
    AIDS; 1999 Jul; 13(10):1249-53. PubMed ID: 10416530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS across Europe, 1994-98: the EuroSIDA study.
    Mocroft A; Katlama C; Johnson AM; Pradier C; Antunes F; Mulcahy F; Chiesi A; Phillips AN; Kirk O; Lundgren JD
    Lancet; 2000 Jul; 356(9226):291-6. PubMed ID: 11071184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AIDS epidemic in Lyon: patient characteristics and defining illnesses between 1985 and 2000.
    Gayet-Ageron A; Baratin D; Marceillac E; Allard R; Peyramond D; Chidiac C; Trepo C; Livrozet JM; Touraine JL; Ritter J; Sepetjan M; Fabry J; Vanhems P
    HIV Med; 2004 May; 5(3):163-70. PubMed ID: 15139982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection.
    Gebo KA; Gallant JE; Keruly JC; Moore RD
    J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1028-33. PubMed ID: 15247555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.